Odonate Therapeutics, Inc.
Odonate Therapeutics, Inc. (ODT) is a publicly traded company in the Unknown sector. Across all available filings, 14 corporate insiders have executed 369 transactions totaling $220.5M, demonstrating a bullish sentiment with $179.2M in net insider flow. The most recent transaction on Dec 10, 2021 involved a sale of 545,000 shares valued at $844.8K.
ODT Insider Activity Summary
Who Is Buying ODT Stock?
No significant insider buying has been recorded for ODT in the recent period.
Who Is Selling ODT Stock?
No significant insider selling has been recorded for ODT in the recent period.
Is Odonate Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ODT is bullish with an Insider Alignment Score of 91/100 and a net flow of $179.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ODT Frequently Asked Questions
Understanding ODT Insider Activity
Insider trading at Odonate Therapeutics, Inc. (ODT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 14 insiders are actively trading ODT stock, having executed 369 transactions in the past 90 days. The most active insider is Capital Partners Lp Tang (Executive), who has made 34 transactions totaling $54.0M.
Related Tools
Track Odonate Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ODT file new Form 4 transactions